The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.

There is increasing evidence that frontotemporal dementia and amyotrophic lateral sclerosis are part of a disease continuum. Recently, a hexanucleotide repeat expansion in C9orf72 was identified as a major cause of both sporadic and familial frontotemporal dementia and amyotrophic lateral sclerosis. The aim of this study was to investigate clinical and neuropathological characteristics of hexanucleotide repeat expansions in C9orf72 in a large cohort of Dutch patients with frontotemporal dementia. Repeat expansions were successfully determined in a cohort of 353 patients with sporadic or familial frontotemporal dementia with or without amyotrophic lateral sclerosis, and 522 neurologically normal controls. Immunohistochemistry was performed in a series of 10 brains from patients carrying expanded repeats using a panel of antibodies. In addition, the presence of RNA containing GGGGCC repeats in paraffin-embedded sections of post-mortem brain tissue was investigated using fluorescence in situ hybridization with a locked nucleic acid probe targeting the GGGGCC repeat. Hexanucleotide repeat expansions in C9orf72 were found in 37 patients with familial (28.7%) and five with sporadic frontotemporal dementia (2.2%). The mean age at onset was 56.9 ± 8.3 years (range 39-76), and disease duration 7.6 ± 4.6 years (range 1-22). The clinical phenotype of these patients varied between the behavioural variant of frontotemporal dementia (n = 34) and primary progressive aphasia (n = 8), with concomitant amyotrophic lateral sclerosis in seven patients. Predominant temporal atrophy on neuroimaging was present in 13 of 32 patients. Pathological examination of the 10 brains from patients carrying expanded repeats revealed frontotemporal lobar degeneration with neuronal transactive response DNA binding protein-positive inclusions of variable type, size and morphology in all brains. Fluorescence in situ hybridization analysis of brain material from patients with the repeat expansion, a microtubule-associated protein tau or a progranulin mutation, and controls did not show RNA-positive inclusions specific for brains with the GGGGCC repeat expansion. The hexanucleotide repeat expansion in C9orf72 is an important cause of frontotemporal dementia with and without amyotrophic lateral sclerosis, and is sometimes associated with primary progressive aphasia. Neuropathological hallmarks include neuronal and glial inclusions, and dystrophic neurites containing transactive response DNA binding protein. Future studies are needed to explain the wide variation in clinical presentation.

[1]  M. Nalls,et al.  The chromosome 9 ALS and FTD locus is probably derived from a single founder , 2012, Neurobiology of Aging.

[2]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[3]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[4]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[5]  Koji Abe,et al.  Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. , 2011, American journal of human genetics.

[6]  Marzena Wojciechowska,et al.  Cellular toxicity of expanded RNA repeats: focus on RNA foci , 2011, Human molecular genetics.

[7]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[8]  C. Troakes,et al.  Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43 , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.

[9]  D. Knopman,et al.  Predicting survival in frontotemporal dementia with motor neuron disease , 2011, Neurology.

[10]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[11]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[12]  D. Hernandez,et al.  Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p , 2011, Journal of Neurology.

[13]  Efstathios D. Gennatas,et al.  TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia , 2010, Neurology.

[14]  Nick C Fox,et al.  Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  H. Akiyama,et al.  Frontotemporal lobar degeneration with motor neuron disease showing severe and circumscribed atrophy of anterior temporal lobes , 2010, Journal of the Neurological Sciences.

[16]  David Heckerman,et al.  Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study , 2010, The Lancet Neurology.

[17]  J. Hodges,et al.  Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. , 2010, Archives of neurology.

[18]  B. Boeve,et al.  Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  C. Geula,et al.  Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation , 2010, Neurology.

[20]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[21]  T. Batchelor,et al.  Primary central nervous system lymphoma. , 2010, Archives of neurology.

[22]  M. J. Fresnadillo Martínez,et al.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.

[23]  Peter K. Todd,et al.  RNA‐mediated neurodegeneration in repeat expansion disorders , 2009, Annals of neurology.

[24]  J. Hodges,et al.  Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. , 2010, Brain : a journal of neurology.

[25]  D. Na,et al.  Semantic dementia combined with motor neuron disease , 2009, Journal of Clinical Neuroscience.

[26]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[27]  S. Heath,et al.  Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease , 2009, Neurology.

[28]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[29]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[30]  W. Kamphorst,et al.  Distinct genetic forms of frontotemporal dementia , 2008, Neurology.

[31]  T. Kohriyama,et al.  White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin , 2008, Acta Neuropathologica.

[32]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[33]  A. Kakita,et al.  TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia , 2007, Acta Neuropathologica.

[34]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[35]  W. Kamphorst,et al.  TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. , 2007, Brain : a journal of neurology.

[36]  V. Meininger,et al.  Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. , 2007, Archives of neurology.

[37]  M. Spillantini,et al.  Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations , 2007, Brain pathology.

[38]  Guy A Rouleau,et al.  Genetics of familial and sporadic amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[39]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[40]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[41]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[42]  F. Baas,et al.  Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.

[43]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[44]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[45]  M. Mesulam,et al.  Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[46]  P. Harper,et al.  Familial motor neurone disease with dementia: phenotypic variation and cerebellar pathology , 2003, Journal of neurology, neurosurgery, and psychiatry.

[47]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[48]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[49]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[50]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[51]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[52]  D. Goudie,et al.  A general method for the detection of large CAG repeat expansions by fluorescent PCR. , 1996, Journal of medical genetics.

[53]  W. Johnson,et al.  Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease , 1994, Neurology.

[54]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[55]  D. C. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1993, Nature.

[56]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[57]  Mulder Dw.  Clinical limits of amyotrophic lateral sclerosis. , 1982 .